Novel tRNA synthetase inhibitors to treat drug resistant Gram-negative infections
Lead Participant:
OXFORD DRUG DESIGN LIMITED
Abstract
Awaiting Public Project Summary
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| OXFORD DRUG DESIGN LIMITED | £1,980,007 | £ 1,980,007 |
Participant |
||
| GLOBAL CITIES LIMITED |
People |
ORCID iD |
| Paul Finn (Project Manager) |